The present application describes compounds according to Formula I, wherein Q, R.sup.1, R.sup.2 and X are described herein, that are useful as Estrogen Receptor Beta (ER.beta.) modulators. Additionally, the present application describes pharmaceutical compositions containing the compounds according to Formula I and optionally additional therapeutic agents. Finally, the present application describes methods utilizing the compounds according to Formula I for modulating the function of ER.beta. in the treatment of diseases and disorders associated with ER.beta. such as, for example, bone disorders; cardiovascular diseases; hypercholesterolemia; hypertriglyceridemia; vasomotor disorders; urogenital disorders; prostatic hypertrophy; endometrial hyperplasia; cancer and central nervous system disorders, such as, neurodegenerative disorders. ##STR00001##